Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372424
Status:
COMPLETED
Last Update Posted:
2012-12-28
First Post:
2006-09-05
Brief Title:
Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive
Sponsor:
Organization:
Pfizer